Fumagillin NEW
| Price | $31 | $107 | $213 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Fumagillin | CAS No.: 23110-15-8 |
| Purity: 95.75% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Fumagillin |
| Description | Fumagillin (Amebacilin) is a selective and potent irreversible inhibitor of Methionine aminopeptidase 2 (MetAP2), used as an antibiotic to treat microsporidiosis. |
| In vitro | Fumagillin selectively inhibits the growth of a Δmap1 strain but not a wild-type or a Δmap2 S. cerevisiae strain missing MetAP-2. [1] In budding yeast cells, as a potent inhibitor of angiogenesis, Fumagillin not only reverses the growth inhibitory activity of Vpr, but also inhibits Vpr-dependent viral gene expression upon the infection of human macrophages. [3] Though the toxicity of fumagillin has limited its use for human applications, the analogues using structure-activity relationships relating to its angiogenesis properties may be further explored in the treatment of angiogenesis-dependent diseases. [4] |
| In vivo | In DEN-treated rats, fumagillin (30 mg/kg, i.p.) inhibits both progression of HCC in the liver itself and systemic metastasis. [2] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (21.81 mM), Solution. DMSO : 250 mg/mL (545.21 mM), Sonication is recommended. 10% DMSO+90% Saline : < 10 mg/mL (21.81 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | Parasite | NSC-9168 | NSC 9168 | MetAP2 | Inhibitor | inhibit | Human immunodeficiency virus | HIVProtease | HIV Protease | HIV | Fumagillin | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Stavudine | Emtricitabine | Kanamycin sulfate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Hydroxychloroquine | Lamivudine | Metronidazole | 2-Amino-2-methyl-1-propanol | Doxycycline | Fenpyroximate |
| Related Compound Libraries | Highly Selective Inhibitor Library | Anti-Tumor Natural Product Library | Anti-Parasitic Compound Library | Bioactive Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Natural Product Library | Microbial Natural Product Library | Inhibitor Library | Antiparasitic Natural Product Library | Anti-infective Natural Product Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-16 | ||
| $20.70 |
VIP6Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2026-05-28 | |
| $1.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-12 | |
| $1.00 |
Apeloa production Co.,Limited
|
2025-02-13 | ||
| $15.00 |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-25 | ||
|
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
|
2023-10-23 | |||
|
Jiangsu Magic Biotechnology Co., Ltd
|
2023-07-25 | |||
| $3.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-08-07 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY